Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: An economic analysis

Health Policy and Planning

Volumn 32, Issue 9, 2017, Pages 1256-1266

  Pitt, Catherine ^a   Ndiaye, Mouhamed ^b   Conteh, Lesong ^c   Sy, Ousmane ^b   Hadj Ba, El ^a,d   Cissé, Badara ^a,b   Gomis, Jules F ^d   Gaye, Oumar ^b   Ndiaye, Jean Louis ^b   Milligan, Paul J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c Department of Infectious Disease Epidemiology School of Public Health Imperial College St Mary's Campus   (United Kingdom)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

campaigns; community health workers; cost function; cost variation; intermittent preventive treatment; malaria; mass drug administration; primary health care; Seasonal malaria chemoprevention (SMC); Sub Saharan Africa

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

CHEMOPROPHYLAXIS; CHILD; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FEMALE; HEALTH AUXILIARY; HUMAN; INFANT; MALARIA; MALE; NEWBORN; PRESCHOOL CHILD; SEASON; SENEGAL;

AMODIAQUINE; ANTIMALARIALS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH WORKERS; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALE; PYRIMETHAMINE; SEASONS; SENEGAL; SULFADOXINE;

EID: 85034447003     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czx084     Document Type: Article

References (37)

1. Altman N, Krzywinski M. 2017. Points of significance: interpreting P values. Nature Methods 14: 213-4.
2. Ba EH, Pitt C, Dial Y et al. 2017. Implementation, coverage and equity of large-scale door-To-door delivery of seasonal malaria chemoprevention to children under 10 years of age in Senegal. [Working Paper].
3. Bojang KA, Akor F, Conteh L et al. 2011. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: A randomised controlled trial. PLoS Medicine 8: e1000409.
4. Brooker S, Kabatereine NB, Fleming F, Devlin N. 2008. Cost and costeffectiveness of nationwide school-based helminth control in Uganda: intracountry variation and effects of scaling-up. Health Policy and Planning 23: 24-35.
5. Bureau of Labor Statistics. 2013. Consumer Price Index Inflation Calculator. http://www.bls.gov/data/inflation-calculator.htm. 4 April 2011
6. Chen X, Ender P, Mitchell M, Wells C. 2003. Regression diagnostics. Regression with Stata. http://stats.idre.ucla.edu/stata/webbooks/reg/chapter2/stata-webbooksregressionwith-statachapter-2-regression-diagnostics/.
7. Cisse B, Ba EH, Sokhna C et al. 2016. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: A Stepped-Wedge cluster-randomised trial. PLoS Medicine 13: e1002175.
8. Conteh L, Patouillard E, Kweku M et al. 2010. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS ONE 5: e12223.
9. Dicko A, Diallo AI, Tembine I et al. 2011. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-Treated bednet in Mali: A randomised, double-blind, placebo-controlled trial. PLoS Medicine 8: e1000407.
10. Drake TL, Okello G, Njagi K et al. 2011. Cost analysis of school-based intermittent screening and treatment of malaria in Kenya. Malaria Journal 10: 273.
11. Fiedler JL, Mubanga F, Siamusantu W et al. 2014. Child Health Week in Zambia: costs, efficiency, coverage and a reassessment of need. Health Policy and Planning 29: 12-29.
12. Goodman C, Coleman PG, Mills AJ. 2000. Economic Analysis of Malaria Control in Sub-Saharan Africa. Geneva: Global Forum for Health Research, World Health Organization.
13. Guinness L, Kumaranayake L, Hanson K. 2007. A cost function for HIV prevention services: is there a 0u0-shape? Cost Effectiveness and Resource Allocation 5: 13.
14. Konate AT, Yaro JB, Ouedraogo AZ et al. 2011. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-Treated bednet in Burkina Faso: A randomised, double-blind, placebo-controlled trial. PLoS Medicine 8: e1000408.
15. Kweku M, Webster J, Adjuik M et al. 2009. Options for the delivery of intermittent preventive treatment for malaria to children: A community randomised trial. PLoS ONE 4: e7256.
16. Lépine A, Chandrashekar S, Shetty G et al. 2016. What determines HIV prevention costs at scale? Evidence from the Avahan programme in India. Health Economics 25: 67-82.
17. Lépine A, Vassall A, Chandrashekar S, Blanc E, Le Nestour A. 2015. Estimating unbiased economies of scale of HIV prevention projects: A case study of Avahan. Social Science and Medicine 131: 164-72.
18. Malaria Consortium. 2016. Projects: ACCESS-SMC. http://www.malariacon sortium.org/what-we-do/projects/41/access-smc, accessed 11 July 2016.
19. Möhring K. 2012. The Fixed Effect as an Alternative to Multilevel Analysis for Cross-National Analyses. Cologne: University of Cologne (GK Soclife working paper 16).
20. NDiaye JL, Cisse B, Ba EH et al. 2016. Safety of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine when delivered to children under 10 years of age by district health services in Senegal: results from a Stepped-Wedge cluster randomized trial. PLoS ONE 11: e0162563.
21. Nonvignon J, Aryeetey GC, Issah S et al. 2016. Cost-effectiveness of seasonal malaria chemoprevention in upper west region of Ghana. Malaria Journal 15: 367. DOI: 10.1186/s12936-016-1418-z
22. OANDA. Historic Currency Converter. http://www.oanda.com/convert/fxhis tory, accessed 1 September 2012.
23. Patouillard E, Conteh L, Webster J et al. 2011. Coverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan, Ghana. PLoS ONE 6: e24871.
24. Pitt C, NDiaye M, Patouillard EPM, Conteh L. 2011. Economic Report for the WHO Technical Expert Group Meeting on Intermittent Preventive Treatment of Malaria in Children.
25. PNLP. 2015. Bulletin epidemiologique annuel 2014 du plaudisme au Senegal. Programme Nationale de Lutte Contre le Paludisme. http://www.pnlp.sn/telechargements/Rapports/BULLETIN-EPIDEMIOLOGIQUE-ANNUEL-2014-DU-PALUDISME-AU-SENEGAL.pdf, accessed 5 August 2016.
26. Ross A, Maire N, Sicuri E, Smith T, Conteh L. 2011. Determinants of the costeffectiveness of intermittent preventive treatment for malaria in infants and children. PLoS ONE 6: e18391.
27. Siapka M, Remme M, Obure CD et al. 2014. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low-And middle-income countries. Bulletin of the World Health Organization 92: 499-511AD.
28. Sinclair D, Meremikwu M, and Garner P. 2011. Seasonal Malaria Chemoprevention fo preventing malaria morbidity in children aged less than 5 years living in areas of marked seasonal transmission: GRADE tables to assist guideline development and recommendations. Background document for inaugural MPAC meeting.
29. Temperley M, Mueller DH, Njagi JK et al. 2008. Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya. Malaria Journal 7: 196.
30. Vassall A, Mangham-Jefferies L, Gomez GB, Pitt C, Foster N. 2016. Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries. Health Economics 25: 95-115.
31. White MT, Conteh L, Cibulskis R, Ghani AC. 2011. Costs and costeffectiveness of malaria control interventions-A systematic review. Malar Journal 10: 337.
32. WHO Global Malaria Programme, 2016, World Malaria Report 2016. Geneva, Switzerland, World Health Organization
33. Wilson AL. 2011. A systematic review and meta-Analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE 6: e16976.
34. World Bank 2017. Country and Lending Groups. Washington, DC: World Bank Group.
35. World Health Organization 2012. WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. March 2012. (in English and French).
36. World Health Organization, 2017. Global Health Expenditure Database. Geneva: WHO
37. World Health Organization/Global Malaria Program Technical Expert Group on Preventive Chemotherapy. 2011. Report of the technical consultation on Seasonal Malaria Chemoprevention (SMC), 4-6 May 2011. http://www.who.int/malaria/publications/atoz/smc-report-Teg-meetingmay2011.pdf. 30 June 2017